(19)
(11) EP 2 953 957 A1

(12)

(43) Date of publication:
16.12.2015 Bulletin 2015/51

(21) Application number: 14706210.3

(22) Date of filing: 07.02.2014
(51) International Patent Classification (IPC): 
C07H 15/18(2006.01)
A61P 31/00(2006.01)
A61P 35/00(2006.01)
A61P 29/00(2006.01)
A61K 31/7032(2006.01)
A61P 33/00(2006.01)
A61P 37/00(2006.01)
(86) International application number:
PCT/US2014/015286
(87) International publication number:
WO 2014/124245 (14.08.2014 Gazette 2014/33)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 08.02.2013 US 201361762591 P
14.03.2013 US 201313803972
02.07.2013 US 201361842149 P

(71) Applicants:
  • Vaccinex, Inc.
    Rochester, NY 14620 (US)
  • Albert Einstein College of Medicine of Yeshiva University
    Bronx, NY 10461 (US)

(72) Inventors:
  • PORCELLI, Steven A.
    Hartsdale, New York 10530-1657 (US)
  • ZAUDERER, Maurice
    Pittsford, New York 14534 (US)

(74) Representative: Bentham, Andrew 
J A Kemp 14 South Square Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) MODIFIED GLYCOLIPIDS AND METHODS OF MAKING AND USING THE SAME